OpenLegislation

Division C Characteristics of the modified organism

United Kingdom

Original text. Later amendments are not shown.

  1. 1..

    Information relating to the genetic modification:

    1. (a)

      methods used for the modification;

    2. (b)

      methods used to construct and introduce the insert(s) into the recipient or to delete a sequence;

    3. (c)

      description of the insert and/or vector construction;

    4. (d)

      purity of the insert from any unknown sequence and information on the degree to which the inserted sequence is limited to the DNA required to perform the intended function;

    5. (e)

      methods and criteria used for selection;

    6. (f)

      sequence, functional identity and location of the altered/inserted/deleted nucleic acid segment(s) in question with particular reference to any known harmful sequence.

  2. 2..

    Information on the final GMO:

    1. (a)

      description of genetic trait(s) or phenotypic characteristics and in particular any new traits and characteristics which may be expressed or no longer expressed;

    2. (b)

      structure and amount of any vector and/or donor nucleic acid remaining in the final construction of the modified organism;

    3. (c)

      stability of the organism in terms of genetic traits;

    4. (d)

      rate and level of expression of the new genetic material. Method and sensitivity of measurement;

    5. (e)

      activity of the expressed protein(s);

    6. (f)

      description of identification and detection techniques including techniques for the identification and detection of the inserted sequence and vector;

    7. (g)

      sensitivity, reliability (in quantitative terms) and specificity of detection and identification techniques;

    8. (h)

      history of previous releases or uses of the GMO;

    9. (i)

      considerations for human health and animal health, as well as plant health:

      1. (i)

        toxic or allergenic effects of the GMOs and/or their metabolic products;

      2. (ii)

        comparison of the modified organism to the donor, recipient or (where appropriate) parental organism regarding pathogenicity;

      3. (iii)

        capacity for colonisation;

      4. (iv)

        if the organism is pathogenic to humans who are immunocompetent:

        • diseases caused and mechanism of pathogenicity including invasiveness and virulence,

        • communicability,

        • infective dose,

        • host range, possibility of alteration,

        • possibility of survival outside of human host,

        • presence of vectors or means of dissemination,

        • biological stability,

        • antibiotic resistance patterns,

        • allergenicity,

        • availability of appropriate therapies;

      5. (v)

        other product hazards.